Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.
Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, Ben-Zeev R, Lehavi-Regev D, Katz MN, Pevsner-Fischer M, Gertler A, Halpern Z, Harmelin A, Aamar S, Serradas P, Grosfeld A, Shapiro H, Geiger B, Elinav E.
Science. 2018 Mar 23;359(6382):1376-1383. doi: 10.1126/science.aar3318. Epub 2018 Mar 8.
PMID:29519916
Molecular characterization of enteropathogenic Escherichia coli isolated from patients with gastroenteritis in a tertiary referral hospital of northeast India.
Roy S, Bhattacharjee B, Mazumder PB, Bhattacharjee M, Dhar D, Bhattacharjee A.
Indian J Med Microbiol. 2024 Jan-Feb;47:100535. doi: 10.1016/j.ijmmb.2024.100535. Epub 2024 Feb 15.
PMID:38350526
[Enteropathogenic Escherichia coli].
Kvittingen J.
Tidsskr Nor Laegeforen. 1966 Jul 1;86(13):977-80.
PMID:5338786
Epidemiology of Enteroaggregative, Enteropathogenic, and Shiga Toxin-Producing Escherichia coli Among Children Aged <5 Years in 3 Countries in Africa, 2015-2018: Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Ochieng JB, Powell H, Sugerman CE, Omore R, Ogwel B, Juma J, Awuor AO, Sow SO, Sanogo D, Onwuchekwa U, Keita AM, Traoré A, Badji H, Hossain MJ, Jones JCM, Kasumba IN, Nasrin D, Roose A, Liang Y, Jamka LP, Antonio M, Platts-Mills JA, Liu J, Houpt ER, Mintz ED, Hunsperger E, Onyango CO, Strockbine N, Widdowson MA, Verani JR, Tennant SM, Kotloff KL.